EyePoint Pharmaceuticals to Build GMP Mfg. Facility in Northbridge, MA
EyePoint Pharmaceuticals, Inc., a company developing and commercializing therapeutics for serious eye disorders, has entered...
CytoReason Licenses IBD Disease Model to Sanofi in Expanded Alliance
CytoReason, a pioneer in computational disease modeling, expanded its collaboration with Sanofi. The multiyear collaboration...
The EU Antibiotic Shortage Is Being Monitored Very Closely
The current EU antibiotic shortages are being closely watched, according to the Executive Steering Group...
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene...
Cryoport, Inc.,a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences...
FDA Looks To Make Edits To The Current COVID-19 Vaccines
The US FDA intends to simplify the COVID-19 vaccine process to make it look more...
Sai Life Sciences Opens High-Potency API Manufacturing Facility
Sai Life Sciences, one of India's fastest growing contract research, development and manufacturing organizations (CRO-CDMO),...
Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
Charles River Laboratories International, Inc. and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in...
Forge Biologics Receives PRIME Designation from EMA for Novel Gene Therapy
Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), said that the European...
Microbiome Industry Explores Hong Kong As APAC Region Centre
To host the Microbiome Summit 2023 at the Hong Kong Science Park, the medicine faculty...
Price Negotiations For 10 US Prescription Drugs To Be Shared
A senior Biden White House official said on January 11 that the U.S. administration will...